Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2002
03/07/2002US20020028831 Phenylpyridine derivatives useful as phosphodiesterase inhibitors
03/07/2002US20020028812 Phenylalanine derivatives
03/07/2002US20020028810 Substituted N-( indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
03/07/2002US20020028809 Heterocyclic compounds having effect of activating a4beta2 nicotinic acetylcholine receptors
03/07/2002DE10042064A1 Chinazoline, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Quinazolines, medicaments containing these compounds, their use and process for their preparation
03/07/2002DE10042062A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Hertellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their Hertel Lung
03/07/2002DE10042060A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation
03/07/2002DE10042059A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation
03/07/2002DE10042058A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation
03/07/2002CA2420673A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
03/07/2002CA2420363A1 Pyrazole derivatives and their use as protein kinase inhibitors
03/07/2002CA2420178A1 Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists
03/07/2002CA2419255A1 Compounds containing a bicyclic ring system useful as alpha v beta 3 antagonists
03/06/2002EP1184373A1 Tricyclic compounds
03/06/2002EP1184368A1 Intermediates for pesticidal tris-oximino heterocyclic compounds
03/06/2002EP1183254A1 Substituted bicyclic heteroaryl compounds as integrin antagonists
03/06/2002EP1183252A1 New pharmaceutically active compounds
03/06/2002EP1183245A1 Selective npy (y5) antagonists
03/06/2002EP1183239A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
03/06/2002EP1183234A1 INHIBITORS OF FACTOR Xa
03/06/2002EP1183229A1 Glucagon antagonists/inverse agonists
03/06/2002EP1183019A2 Ace-2 inhibiting compounds and methods of use thereof
03/06/2002EP0994865B1 Triazole compounds and the use thereof as dopamine-d 3-ligands
03/06/2002EP0728748B1 Benzodiazepine derivatives
03/06/2002EP0695295B1 3-(hetero)aryl carboxylic acid derivatives, methods of preparing them and intermediates used in their preparation
03/06/2002CN1080257C Guanidine derivatives
03/06/2002CA2356797A1 Combination treatment for depression and anxiety
03/05/2002US6353110 Key intermediate in the synthesis of an endothelin antagonist; arylation of a 3-oxopropylpyridine with lithium 1,3 benzenedioxole then hydrolysis
03/05/2002US6353010 Enzyme inhibitors tumor necrosis factor and phosphodiesterase for antiinflammatory agents
03/05/2002US6353006 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
03/05/2002US6352994 Nervous system disorders; psychological disorders
03/05/2002US6352982 4,1-benzoxazepines, their analogues, and their use as somatostatin agonists
03/05/2002US6352981 Treat disorders which respond to dopamine d.sub.3 ligands such as schistosomiasis, schizophrenia, depression, neuroses or psychoses
03/05/2002US6352958 Pre- and post-emergence herbicides
03/05/2002CA2272138C Pyrazolopyrimidine and pyrazolopyridine compounds having crf antagonist activity
02/2002
02/28/2002WO2002016353A1 Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatory disorders
02/28/2002WO2002016340A1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
02/28/2002WO2002016332A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
02/28/2002WO2002016331A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
02/28/2002WO2002016327A1 Benzimidazoles and analogues and their use as neutrophil inhibitors
02/28/2002WO2002016324A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
02/28/2002WO2002016318A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
02/28/2002WO2002015940A2 Solution of an oxazolidinone antibiotic drug
02/28/2002WO2002015909A1 Substituted piperidines as melanocortin receptor agonists
02/28/2002WO2001081324B1 Benzoxazine derivatives and benzothiazine derivatives having nos-inhibitory and antioxidant properties
02/28/2002WO2001079167A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
02/28/2002WO2001077080A3 Pyrazole compounds having anti proliferative activity
02/28/2002WO2000040569A9 2-amino-benzoxazinone derivatives for the treatment of obesity
02/28/2002US20020026059 Use as microbicides in crop protection
02/28/2002US20020026050 Thrombin receptor antagonists
02/28/2002US20020026034 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties
02/28/2002US20020025963 Novel guanidine mimics as factor Xa inhibitors
02/28/2002US20020025957 Anticoagulants, cardiovascular disorders
02/28/2002US20020025948 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
02/28/2002US20020025910 3-heterocycly1 - substituted benzoyl derivatives
02/28/2002DE10041470A1 New 6-substituted 12,13-(cyclopropyl or azacyclopropyl)-epothilone derivatives, useful as cell division regulators for treating e.g. malignant tumors, psoriasis or arthritis
02/28/2002DE10040525A1 New 6-acylamino-4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors or respiratory or gastrointestinal diseases
02/28/2002CA2419597A1 Solution composition of an oxazolidinone antibiotic drug having enhanced drug loading
02/28/2002CA2419310A1 Substituted piperidines as melanocortin receptor agonists
02/28/2002CA2418134A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
02/28/2002CA2418104A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
02/28/2002CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
02/28/2002CA2415852A1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
02/27/2002EP1181935A2 Agent for treating mental disorders associated with cerebrovascular disorders
02/27/2002EP1181294A1 Novel derivatives and analogues of galanthamin
02/27/2002EP1181288A1 Bicyclic oxazolidinones as antibacterial agent
02/27/2002EP1181287A1 Sulfonamide compounds with pharmaceutical activity
02/27/2002EP1181282A2 Benzothiazinone and benzoxazinone compounds
02/27/2002EP1181280A1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
02/27/2002EP1181014A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD
02/27/2002EP0927178B1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
02/27/2002EP0783495B1 Quinoxaline derivatives useful in therapy
02/27/2002CN1337961A Heteroaryl amidines, methyl amidiues and guanidines as protease inhibitors
02/27/2002CN1337956A New Morpholinobenzamide salts
02/27/2002CN1079794C Ether compound, use thereof, and intermediate for producing the compound
02/26/2002US6350774 Antithrombotic agents
02/26/2002US6350767 Growth hormone release stimulant
02/26/2002US6350760 Substituted piperidines as melanocortin-4 receptor agonists
02/26/2002US6350720 Controlling weeds
02/26/2002CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present
02/26/2002CA2178302C Indole, indazole and benzisoxazole derivatives; process for preparing the same and pharmaceutical compositions containing them
02/21/2002WO2002014545A2 Method for determining weather a test compound binds to a large rna target
02/21/2002WO2002014317A2 Substituted pyrazoles
02/21/2002WO2002014315A2 Substituted pyrazoles
02/21/2002WO2002014310A1 2-[5-AMINO-6-OXO-2-PHENYL-1,6-DIHYDRO-1-PYRIMIDYL]-N-[1-(2-[5-t-BUTYL-1,3,4-OXADIAZOLYL]CARBONYL)-2-(R,S)-METHYLPROPYL]ACETAMIDE HYDROCHLORIDE
02/21/2002WO2002014291A1 PPARδ ACTIVATORS
02/21/2002WO2002014273A1 Indoline derivatives as 5ht2c antagonists
02/21/2002WO2002014271A1 Proline derivatives and use thereof as drugs
02/21/2002WO2002014270A1 New amidino derivatives and their use as thrombin inhibitors
02/21/2002WO2002013824A1 Cyclopentyl modulators of chemokine receptor activity
02/21/2002WO2002006247A8 Substituted amidoalkyl-uracils as parp inhibitors
02/21/2002WO2001081328A3 Thiazolidinedione analogues and their use for the treatment of diabetes
02/21/2002WO2001060820A3 Matrix metalloproteinase inhibitors and uses thereof
02/21/2002WO2001058869B1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
02/21/2002WO2000054729A8 Heterocyclic aromatic compounds useful as growth hormone secretagogues
02/21/2002US20020022645 Administering benzofuran derivative for therapy of disease state that is capable of being modulated by inhibition of phosphodiesterase IV or Tumour Necrosis Factor
02/21/2002US20020022625 Betamimetics having a long-lasting activity, processes for preparing them, and their use as medicaments
02/21/2002DE10039477A1 Heterocyclylalkylazol-Derivate und ihre Verwendung als Schädlingsbekämpfungsmittel Heterocyclylalkylazol derivatives and their use as pesticides
02/21/2002DE10038639A1 New and known N-aryl 2-hydroxy-omega-arylalkanamide derivatives, useful e.g. for treating inflammatory diseases such as rheumatism
02/21/2002CA2419550A1 Substituted pyrazoles